About AGC Biologics
AGC Biologics is a company based in Bothell (United States) founded in 2018 by Patricio E Massera. It operates as a B2B and Enterprise Contracts. AGC Biologics has completed 1 acquisition, including MolMed. AGC Biologics offers products and services including cGMP Manufacturing, Tech Transfer, Process Development, Analytical Development, and Fill and Finish. AGC Biologics operates in a competitive market with competitors including Bionova Scientific, Avid Bioservices, Just Biotherapeutics, JHL Biotech and ProBioGen AG, among others.
- Headquarter Bothell, United States
- Founders Patricio E Massera
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Agc Biologics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AGC Biologics
AGC Biologics offers a comprehensive portfolio of products and services, including cGMP Manufacturing, Tech Transfer, Process Development, Analytical Development, and Fill and Finish.
Offers manufacturing for biologics under strict cGMP standards.
Facilitates technology transfer for biopharmaceutical projects.
Develops processes for upstream and downstream biologics production.
Provides analytical testing for product safety and purity.
Handles final packaging and finishing for drug products.
People of AGC Biologics
Unlock access to complete
Software Development Team
105 people
Leadership Team
36 people
Senior Team
31 people
Product Management Team
20 people
Sales and Marketing
20 people
Human Resources and Administration
16 people
Manufacturing Team
15 people
QC Team
14 people
Unlock access to complete
Funding Insights of AGC Biologics
Detailed funding history for AGC Biologics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AGC Biologics
AGC Biologics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MolMed.
Investment portfolio details for AGC Biologics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of gene and cell therapies for the treatment of cancer and rare diseases
|
Locked | Locked | 1996 | Locked |
Complete acquisition details for AGC Biologics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - AGC Biologics
Detailed financials for AGC Biologics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Agc Biologics Comparisons
Peer comparison for AGC Biologics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AGC Biologics
AGC Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionova Scientific, Avid Bioservices, Just Biotherapeutics, JHL Biotech and ProBioGen AG, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Mammalian cell culture biologics are developed through contract research services.
|
|
| Locked | Locked | Locked |
Drug substance development, analytical, and compliance services are provided.
|
|
| Locked | Locked | Locked |
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
|
|
| Locked | Locked | Locked |
Contract manufacturing solutions for biologics are provided to Asian companies.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars
|
|
| Locked | Locked | Locked |
Biologics CDMO specializing in mammalian cell line based manufacturing
|
Detailed competitors of AGC Biologics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Agc Biologics
Complete news archive for AGC Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AGC Biologics
AGC Biologics was founded in 2018.
AGC Biologics is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Patricio E Massera is the current CEO of AGC Biologics. They have also founded this company.
AGC Biologics offers comprehensive services as a CDMO, including tech transfer, process development, and cGMP manufacturing for protein-based biologics and advanced therapies. They operate globally with facilities in the US, Europe, and Asia, supporting clients in bringing new biopharmaceuticals to market through innovative platforms like viral vectors and cell therapy. Their focus includes quality systems and analytical development to ensure compliance and improve patient outcomes.
AGC Biologics's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.
AGC Biologics offers cGMP Manufacturing, Tech Transfer, Process Development, Analytical Development, and Fill and Finish.
AGC Biologics has made 1 acquisition, including MolMed.